September 24, 2014 by Arezu Sarvestani
Zimmer and Biomet provide updates following the 2nd in a series of “Integration Summits” where company leadership is fleshing out the details of their $13 billion merger.
Leadership at Zimmer (NYSE:ZMH) and Biomet have been on merger overdrive in recent weeks, holding summits and hosting presentations as the companies navigate the tricky business of a $13 billion merger.
The orthopedics makers recently hosted the 2nd in a series of Integration Summits taking place monthly, where teams comprised of members from each company look for growth opportunities, hash out tax and regulatory issues and strategize on how best to bring these industry titans together.
Integration managers and company executives have also been on tour, hosting regular in-person and webcast Town Hall meetings and running the conference circuit to keep employees, shareholders and analysts apprised of the progress made since the merger was announced in April. Several of Biomet’s and Zimmer’s facilities around the world will also host integration planning team members over the next few months as company leadership seeks to get an “impression” of each site and its production capabilities.
